Genmab buys PDL Biopharma antibody plant for $240M

02/21/2008 | American City Business Journals

California-based PDL Biopharma completed the $240 million sale of its antibody manufacturing plant in Minnesota to Danish company Genmab A/S in a move to reduce its assets. The deal, which includes access to a leased development lab and other equipment, allows Genmab to supply clinical quantities of antibodies for PDL studies and retain the plant's 170 workers.

View Full Article in:

American City Business Journals

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Director, Site Quality Management
CareFusion
Minneapolis, MN
In house Compliance Officer
Confidential
Pompano Beach, FL
Clinical Project Manager
Abiomed, Inc.
Danvers, MA
Sr. Manager, Regulatory Affairs - International
Integra LifeSciences
Plainsboro, NJ
Associate - Food and Drug
Keller and Heckman LLP
Washington, DC